Adherence

While 82% of children are receiving CDC-recommended dosing of Prevnar 13® nationally, vaccination rates vary among states2,3
Percentage of children in each state who have received all 4 recommended doses of Prevnar 13® in 2017†
*At 2, 4, 6, and 12 to 15 months of age. In children 6 years through 17 years of age, Prevnar 13® is administered as a single dose.1
†Based on the CDC's 2017 National Immunization Survey of 15,333 children aged 19-35 months. Data were collected in all 50 states, the District of Columbia, selected local areas, and territories. Data were weighted to be representative of the US population of children aged 19-35 months.2
CDC=Centers for Disease Control and Prevention.
Healthy People 2020 goal for children aged 19 to 35 months to receive at least 4 doses of pneumococcal conjugate vaccine is 90%4
Pfizer Home

Clinical Information

Rates of IPD
Take a year-by-year look at
the rates of IPD since the
introduction of pneumococcal conjugate vaccinations
See the data
Dosing
Review the CDC-recommended dosing schedule for Prevnar 13®
View now
Resources
Offer resources that
may help with
well-visit
attendance
Look now